在高血压中凝血的不规则性
Saira Rafaqat1, Amber Khalid2, Saira Riaz3
1Department of Zoology (Molecular Physiology), Lahore College for Women University, Lahore, Punjab, Pakistan. saera.rafaqat@gmail.com.
高血压患者的凝血因子,如D-二聚合物和纤维素因子升高,这表明它们在疾病发展和并发症中的作用. 这些标记与高血压的严重程度和持续时间相关,突出了它们在理解高血压病理学方面的重要性.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 高血压是一种复杂的疾病,具有多因素的起源.
- 人们越来越认识到凝血系统在高血压发病过程中的作用.
- 了解这些联系对于开发新型治疗策略至关重要.
研究的目的:
- 审查凝血因子在高血压发展中的关键作用.
- 总结关键的凝血标志物及其与高血压疾病的关联.
- 突出高血压及其并发症的潜在生物标志物.
主要方法:
- 关于研究高血压中的凝血标志物的文献综述.
- 对将特定的凝血因子 (如D-二聚合物,纤维素,P-选择素) 与血压和疾病进展联系起来的数据的分析.
- 对涉及的病理生理机制的发现进行综合.
主要成果:
- 升高的D-二聚合物和纤维素原水平与高血压的严重程度和持续时间相关.
- 血时间和激活的局部血栓塑时间随着血压的增加而增加.
- 血小板激活标记物 (P-选择素,β-血小板球蛋白) 和内皮标记物 (可溶性泌尿酸酶等离子体激活受体,血小板球蛋白) 有关.
- 组织因子和·维勒布兰德因子显示出作为特定高血压条件的生物标志物的潜力.
结论:
- 凝血因子,包括D-二聚合物,纤维素,前激素,P-选择素,可溶性尿激酶激活体受体,血栓模块素,组织因子,组织激活体激活体,·维勒布兰德因子,都在显著地参与高血压的发病.
- 这些标志物可以作为疾病严重程度,持续时间和潜在并发症的指标.
- 对凝血路径的进一步研究可能为高血压管理提供新的途径.
更多相关视频
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
相关概念视频
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis I: Introduction
